Viracta Therapeutics, Inc. (NASDAQ:VIRX), a pharmaceutical company with a market capitalization of just $6 million, is set to be delisted from the Nasdaq Stock Market LLC, with trading of its common ...

The Dow industrials fell more than 400 points, or 1%, but reduced the drop to less than 200 points, or 0.4% one hour into the session.

Fact checked by Stella Osoba Passive investing has often been a proven winner in the long term, but investors still need to ...

Cellectar Biosciences Inc. (NASDAQ:CLRB), a pharmaceutical company with a market capitalization of $10.38 million, has been ...

The Nasdaq Composite is an often-cited stock market index — along with the S&P 500 and the Dow Jones Industrial Average — ...

Looking ahead, Nasdaq anticipates growth in its Financial Technology division within the 10-14% range. The company is also targeting a reduction in non-GAAP expenses to between $2.245 billion and ...

In a turbulent market session, VIRX, the stock of Sunesis Pharmaceuticals (NASDAQ:VIRX), plummeted to a 52-week low, reaching a distressing price level of $0.08. According to InvestingPro data, the ...

Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...

The Texas Stock Exchange (TXSE) is eyeing a 2026 launch after submitting paperwork to operate as a national securities ...

The combined value of all investment products tracking the NDX® ecosystem globally exceeds $500 billion94 Exchange Traded Products track NDX® in ...

OSLO (Reuters) -Pan-European stock exchange Euronext on Tuesday announced it would acquire Nasdaq's Nordic power futures ...

Nasdaq reported a higher fourth-quarter profit on Wednesday, helped by strong demand for the exchange operator's financial ...